《大行》花旗:洛鉬(03993.HK)中期淨利潤略遜預期 目標價11.2元籲買入
花旗研究報告指,洛陽鉬業(03993.HK)發盈喜,料上半年淨利潤介於82億至91億元人民幣,按年增長51.4%至68%,相當於該行全年預測的61%至67%,但略低過該行預期。當中反映次季淨利潤按年增長27%至54%,按季增長8%至31%。公司表示,上半年利潤增長主要受益於銅鈷產品平均售價上升,同時銅銷量上升。
另外,公司上半年銅和鈷產量分別按年升12.7%及13.1%,相當於該行全年預測的54%。反映次季銅和鈷產量分別按年升10%及6.4%,按季升7.3%及0.8%。該行現予目標價11.2元及「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.